Abstract
Preeclampsia is a complex disorder that is characterized by new onset hypertension and proteinuria at or after 20 weeks of gestation. Preeclampsia is a leading cause of maternal and fetal morbidity and mortality. MgSO4 is commonly used to treat severe preeclampsia, but its mechanism of action is poorly understood, and investigations into the effects of MgSO4 during the postpartum period are lacking. In this study, timed-pregnant Sprague-Dawley rats received low-dose lipopolysaccharide (LPS) on gestational day 14 to induce preeclampsia. Maternal and fetal outcomes and the macrophage profile 1 week after delivery were explored. On postpartum day (PD) 7, the maternal systolic blood pressure and urinary protein level were significantly increased, the number of M1 macrophages was increased and the number of M2 macrophages was decreased in the maternal kidney and brain; the median duration of gestation, the number of live fetuses, and the fetal weight/placenta weight ratio were significantly decreased; and the percentage of growth-restricted pups and fetal mortality were significantly increased in preeclampsia rats compared to normal pregnant control rats. Prophylactic MgSO4 decreased blood pressure at PD7, improved pregnancy outcomes, and promoted the polarization of M2 macrophages in the kidney and of M2 microglia in the brain of preeclampsia rats. These findings confirm that the pathophysiology of preeclampsia involves the dysregulation of the inflammatory response and the activation of M1 macrophages in several target organs during pregnancy. MgSO4 prophylaxis attenuates the postpartum effects of preeclampsia by promoting M2 macrophage polarization in the maternal kidney and brain.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Tranquilli AL, Dekker G, Magee L, Roberts J, Sibai BM, Steyn W, et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP. Pregnancy Hypertens. 2014;4:97–104. https://doi.org/10.1016/j.preghy.2014.02.001.
Black KD, Horowitz JA. Inflammatory markers and preeclampsia: a systematic review. Nurs Res. 2018;67:242–51. https://doi.org/10.1097/NNR.0000000000000285.
Tang J, He A, Li N, Chen X, Zhou X, Fan X, et al. Magnesium sulfate-mediated vascular relaxation and calcium channel activity in placental vessels different from nonplacental vessels. J Am Heart Assoc. 2018;7. https://doi.org/10.1161/JAHA.118.009896.
Clayton AM, Shao Q, Paauw ND, Giambrone AB, Granger JP, Warrington JP. Postpartum increases in cerebral edema and inflammation in response to placental ischemia during pregnancy. Brain Behav Immun. 2018;70:376–89. https://doi.org/10.1016/j.bbi.2018.03.028.
Conrad KP, Miles TM, Benyo DF. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol. 1998;40:102–11. https://doi.org/10.1111/j.1600-0897.1998.tb00398.x.
Kara AE, Guney G, Tokmak A, Ozaksit G. The role of inflammatory markers hs-CRP, sialic acid, and IL-6 in the pathogenesis of preeclampsia and intrauterine growth restriction. Eur Cytokine Netw. 2019;30:29–33. https://doi.org/10.1684/ecn.2019.0423.
Kim S, Lee KS, Choi S, Kim J, Lee DK, Park M, et al. NF-kappaB-responsive miRNA-31-5p elicits endothelial dysfunction associated with preeclampsia via down-regulation of endothelial nitric-oxide synthase. J Biol Chem. 2018;293:18989–9000. https://doi.org/10.1074/jbc.RA118.005197.
Li X, Han X, Bao J, Liu Y, Ye A, Thakur M, et al. Nicotine increases eclampsia-like seizure threshold and attenuates microglial activity in rat hippocampus through the alpha7 nicotinic acetylcholine receptor. Brain Res. 2016;1642:487–96. https://doi.org/10.1016/j.brainres.2016.04.043.
Li X, Han X, Yang J, Bao J, Di X, Zhang G, et al. Magnesium sulfate provides neuroprotection in eclampsia-like seizure model by ameliorating neuroinflammation and brain edema. Mol Neurobiol. 2017;54:7938–48. https://doi.org/10.1007/s12035-016-0278-4.
Sibai BM. Magnesium sulfate is the ideal anticonvulsant in preeclampsia-eclampsia. Am J Obstet Gynecol. 1990;162:1141–5. https://doi.org/10.1016/0002-9378(90)90002-o.
Celik Kavak E, Gulcu Bulmus F, Bulmus O, Kavak SB, Kocaman N. Magnesium: does it reduce ischemia/reperfusion injury in an adnexal torsion rat model?. Drug Des Dev Ther. 2018;12:409–15. https://doi.org/10.2147/DDDT.S157115.
Li X, Liu H, Yang Y. Magnesium sulfate attenuates brain edema by lowering AQP4 expression and inhibits glia-mediated neuroinflammation in a rodent model of eclampsia. Behav Brain Res. 2019;364:403–12. https://doi.org/10.1016/j.bbr.2017.12.031.
Zhang YH, He M, Wang Y, Liao AH. Modulators of the balance between M1 and M2 macrophages during pregnancy. Front Immunol. 2017;8:120. https://doi.org/10.3389/fimmu.2017.00120.
Schonkeren D, van der Hoorn ML, Khedoe P, Swings G, van Beelen E, Claas F, et al. Differential distribution and phenotype of decidual macrophages in preeclamptic versus control pregnancies. Am J Pathol. 2011;178:709–17. https://doi.org/10.1016/j.ajpath.2010.10.011.
Faas MM, Schuiling GA, Baller JF, Visscher CA, Bakker WW. A new animal model for human preeclampsia: ultra-low-dose endotoxin infusion in pregnant rats. Am J Obstet Gynecol. 1994;171:158–64. https://doi.org/10.1016/0002-9378(94)90463-4.
Orhan N, Ugur Yilmaz C, Ekizoglu O, Ahishali B, Arican N, Kucuk M, et al. The effects of superoxide dismutase mimetic MnTMPyP on the altered blood-brain barrier integrity in experimental preeclampsia with or without seizures in rats. Brain Res. 2014;1563:91–102. https://doi.org/10.1016/j.brainres.2014.03.029.
Wu WM, Suen JL, Lin BF, Chiang BL. Tamoxifen alleviates disease severity and decreases double negative T cells in autoimmune MRL-lpr/lpr mice. Immunology. 2000;100:110–8. https://doi.org/10.1046/j.1365-2567.2000.00998.x.
He J, Yuan G, Cheng F, Zhang J, Guo X. Mast Cell and M1 macrophage infiltration and local pro-inflammatory factors were attenuated with incretin-based therapies in obesity-related glomerulopathy. Metab Syndr Relat Disord. 2017;15:344–53. https://doi.org/10.1089/met.2017.0057.
Li Z, Zhang Y, Ying Ma J, Kapoun AM, Shao Q, Kerr I, et al. Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia. Hypertension. 2007;50:686–92. https://doi.org/10.1161/HYPERTENSIONAHA.107.092098.
Lee CH, Wen ZH, Chang YC, Huang SY, Tang CC, Chen WF, et al. Intra-articular magnesium sulfate (MgSO4) reduces experimental osteoarthritis and nociception: association with attenuation of N-methyl-D-aspartate (NMDA) receptor subunit 1 phosphorylation and apoptosis in rat chondrocytes. Osteoarthr Cartil. 2009;17:1485–93. https://doi.org/10.1016/j.joca.2009.05.006.
Gao F, Ding B, Zhou L, Gao X, Guo H, Xu H. Magnesium sulfate provides neuroprotection in lipopolysaccharide-activated primary microglia by inhibiting NF-kappaB pathway. J Surg Res. 2013;184:944–50. https://doi.org/10.1016/j.jss.2013.03.034.
American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 134: fetal growth restriction. Obstet Gynecol.2013;121:1122–33. https://doi.org/10.1097/01.AOG.0000429658.85846.f9.
Perucci LO, Correa MD, Dusse LM, Gomes KB, Sousa LP. Resolution of inflammation pathways in preeclampsia-a narrative review. Immunol Res. 2017;65:774–89. https://doi.org/10.1007/s12026-017-8921-3.
Shaw J, Tang Z, Schneider H, Salje K, Hansson SR, Guller S. Inflammatory processes are specifically enhanced in endothelial cells by placental-derived TNF-alpha: Implications in preeclampsia (PE). Placenta. 2016;43:1–8. https://doi.org/10.1016/j.placenta.2016.04.015.
Strevens H, Wide-Swensson D, Hansen A, Horn T, Ingemarsson I, Larsen S, et al. Glomerular endotheliosis in normal pregnancy and pre-eclampsia. BJOG. 2003;110:831–6.
McKinney D, Boyd H, Langager A, Oswald M, Pfister A, Warshak CR. The impact of fetal growth restriction on latency in the setting of expectant management of preeclampsia. Am J Obstet Gynecol. 2016;214:395 e1–7. https://doi.org/10.1016/j.ajog.2015.12.050.
Schiessl B. Inflammatory response in preeclampsia. Mol Asp Med. 2007;28:210–9. https://doi.org/10.1016/j.mam.2007.04.004.
Kemp PA, Gardiner SM, March JE, Rubin PC, Bennett T. Assessment of the effects of endothelin-1 and magnesium sulphate on regional blood flows in conscious rats, by the coloured microsphere reference technique. Br J Pharmacol. 1999;126:621–6. https://doi.org/10.1038/sj.bjp.0702342.
Vishnyakova P, Elchaninov A, Fatkhudinov T, Sukhikh G. Role of the monocyte-macrophage system in normal pregnancy and preeclampsia. Int J Mol Sci. 2019;20. https://doi.org/10.3390/ijms20153695.
Mol BWJ, Roberts CT, Thangaratinam S, Magee LA, de Groot CJM, Hofmeyr GJ. Pre-eclampsia. Lancet. 2016;387:999–1011. https://doi.org/10.1016/S0140-6736(15)00070-7.
Boyle AK, Rinaldi SF, Norman JE, Stock SJ. Preterm birth: Inflammation, fetal injury and treatment strategies. J Reprod Immunol. 2017;119:62–6. https://doi.org/10.1016/j.jri.2016.11.008.
Schutten JC, Joris PJ, Mensink RP, Danel RM, Goorman F, Heiner-Fokkema MR, et al. Effects of magnesium citrate, magnesium oxide and magnesium sulfate supplementation on arterial stiffness in healthy overweight individuals: a study protocol for a randomized controlled trial. Trials. 2019;20:295. https://doi.org/10.1186/s13063-019-3414-4.
Huang Q, Liu L, Hu B, Di X, Brennecke SP, Liu H. Decreased seizure threshold in an eclampsia-like model induced in pregnant rats with lipopolysaccharide and pentylenetetrazol treatments. PLoS ONE 2014;9:e89333. https://doi.org/10.1371/journal.pone.0089333.
Yang H, Kim TH, Lee GS, Hong EJ, Jeung EB. Comparing the expression patterns of placental magnesium/phosphorus-transporting channels between healthy and preeclamptic pregnancies. Mol Reprod Dev. 2014;81:851–60. https://doi.org/10.1002/mrd.22353.
Vigil-De Gracia P, Ramirez R, Duran Y, Quintero A. Magnesium sulfate for 6 vs 24 h post delivery in patients who received magnesium sulfate for less than 8 h before birth: a randomized clinical trial. BMC Pregnancy Childbirth. 2017;17:241. https://doi.org/10.1186/s12884-017-1424-3.
Sugimoto J, Romani AM, Valentin-Torres AM, Luciano AA, Ramirez Kitchen CM, Funderburg N, et al. Magnesium decreases inflammatory cytokine production: a novel innate immunomodulatory mechanism. J Immunol. 2012;188:6338–46. https://doi.org/10.4049/jimmunol.1101765.
Burwick RM, Togioka BM, Speranza RJ, Gaffney JE, Roberts VHJ, Frias AE, et al. Assessment of blood-brain barrier integrity and neuroinflammation in preeclampsia. Am J Obstet Gynecol. 2019;221:269. e1–8. https://doi.org/10.1016/j.ajog.2019.06.024.
de Baaij JH, Hoenderop JG, Bindels RJ. Magnesium in man: implications for health and disease. Physiol Rev. 2015;95:1–46. https://doi.org/10.1152/physrev.00012.2014.
Kreepala C, Luangphiphat W, Villarroel A, Kitporntheranunt M, Wattanavaekin K, Piyajarawong T. Effect of magnesium on glomerular filtration rate and recovery of hypertension in women with severe preeclampsia. Nephron. 2018;138:35–41. https://doi.org/10.1159/000481463.
Suzuki-Kakisaka H, Sugimoto J, Tetarbe M, Romani AM, Ramirez Kitchen CM, Bernstein HB. Magnesium sulfate increases intracellular magnesium reducing inflammatory cytokine release in neonates. Am J Reprod Immunol. 2013;70:213–20. https://doi.org/10.1111/aji.12118.
Rochelson B, Dowling O, Schwartz N, Metz CN. Magnesium sulfate suppresses inflammatory responses by human umbilical vein endothelial cells (HuVECs) through the NFkappaB pathway. J Reprod Immunol. 2007;73:101–7. https://doi.org/10.1016/j.jri.2006.06.004.
Bosio PM, McKenna PJ, Conroy R, O’Herlihy C. Maternal central hemodynamics in hypertensive disorders of pregnancy. Obstet Gynecol. 1999;94:978–84. https://doi.org/10.1016/s0029-7844(99)00430-5.
Paauw ND, Joles JA, Spradley FT, Bakrania B, Zsengeller ZK, Franx A, et al. Exposure to placental ischemia impairs postpartum maternal renal and cardiac function in rats. Am J Physiol Regul Integr Comp Physiol. 2017;312:R664–70. https://doi.org/10.1152/ajpregu.00510.2016.
Tomimatsu T, Mimura K, Endo M, Kumasawa K, Kimura T. Pathophysiology of preeclampsia: an angiogenic imbalance and long-lasting systemic vascular dysfunction. Hypertens Res. 2017;40:305–10. https://doi.org/10.1038/hr.2016.152.
Funding
This work was supported by a grant from the National Natural Science Foundation of China (No. 81801477) and the Ph.D. Programs Foundation of the First Affiliated Hospital of Anhui Medical University in China.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Li, X., Li, L., Tao, L. et al. Magnesium sulfate prophylaxis attenuates the postpartum effects of preeclampsia by promoting M2 macrophage polarization. Hypertens Res 44, 13–22 (2021). https://doi.org/10.1038/s41440-020-0511-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41440-020-0511-4